Marti Technologies, Inc.
New York Stock Exchange ArcaCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Oguz Alper Oktem
- Full Time Employees
- 473
- Sector
- Technology
- Industry
- Software - Application
- Address
- Buyukdere Caddesi No. 237 Istanbul IB Türkiye 34485
- IPO Date
- Aug 30, 2021
- CIK
- 0001852767
- Website
- marti.tech
- Similar Companies
- Business
- Marti Technologies, Inc. (NYSE: MRT) operates as Turkey's leading mobility super app, providing tech-enabled urban transportation services through a proprietary platform supported by software systems and Internet of Things infrastructure. The company offers ride-hailing that matches riders with car, motorcycle, and taxi drivers; delivery services; and a large fleet of rental e-mopeds, e-bikes, and e-scooters; as well as driver subscription packages enabling prepaid rides on daily or weekly bases. Founded in 2018 and headquartered in Istanbul, Turkey, with corporate offices in Grand Cayman, Cayman Islands, Marti primarily serves urban riders in multiple cities across Türkiye. Recent developments include the expansion of ride-hailing services to 10 additional cities in 2025, increasing the addressable population 1.5 times to 42.2 million; the launch of delivery services and integration of public transportation options into its app; announcement of a 2025-2026 investment plan; initiation of a crypto asset treasury strategy; and achievement of 70% year-over-year revenue growth to $14.3 million in the first half of 2025, with projections to nearly double full-year revenue to $34 million.
Company News
MHI Receives Follow-up Order for 8 Two-Car Trains for Singapore's Sengkang-Punggol LRT (SPLRT)
Monte Rosa's MRT-8102 Shows Biomarker Gains in GFORCE-1 Study
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk
Marti Increases Share Repurchase Authorization to $5 Million and Extends Program Through April 2027
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Marti's Ride-Hailing Service Reaches 4.90 Million Riders and 584 Thousand Registered Drivers, Exceeding September 30, 2026 Targets a Month Earlier Than Planned
Marti Technologies: Buy The Inflection Point
Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
Marti Technologies, Inc. (MRT) Q2 2026 Earnings Call Transcript
Marti Technologies H1 Earnings Call Highlights
Marti Achieves Record Second Quarter with 141% Revenue Growth, 77% Gross Profit Margin, Significant Improvement in Profitability, and Increased Guidance
Marti Technologies, Inc. to Report 2026 Second Quarter Results on August 19, 2026
Marti Technologies Launches Ride-Hailing Service in 10 New Cities Across Türkiye
Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
Marti Technologies Increases Fiscal Year 2026 Guidance on Accelerating Growth and Margin Expansion
Marti and Tensor Partner to Deploy Autonomous Vehicles in Türkiye
Marti Technologies Provides Update on Its Share Repurchase Program
Marti's Ride-Hailing Service Reaches 4.30 Million Riders and 532 Thousand Registered Drivers, Exceeding June 30, 2026 Targets
Marti Is Highly Risky, Financially And Operationally